OncoSec Medical Inc (ONCS) Financials

$0.00

$0.00 (0.00%)

As on 25-Aug-2023 09:30EDT

Market cap

$2 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	-0.01	--
Operating Expenses	32.65	37.01	48.38	43.41	30.42	36.11
Operating Profit (EBIT)	-32.65	-37.01	-48.38	-43.41	-30.42	-36.11
Other Income	--	--	--	0.29	0.16	-0.56
Profit before Tax	-32.72	-37.51	-47.58	-43.13	-30.27	-39.14
Provision for Tax	-2.58	-3.33	-2.41	-0.87	0.00	0.00
Profit after Tax (Net Income)	-30.14	-34.18	-45.17	-42.25	-30.28	-39.14
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-14.46	-34.18	-45.17	-42.25	-30.28	-39.14

Liabilities ($ Mln)	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Shareholder's Funds	-5.49	6.12	38.08	13.87	24.28	22.92
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.13	9.13	10.24	6.35	0.64	1.47
Current Liabilities	7.23	6.63	7.96	9.68	4.98	5.85
Total Liabilities	16.10	21.88	56.28	29.90	29.89	30.25

Assets ($ Mln)	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Non-Current Assets	2.43	6.65	7.10	7.08	1.38	1.62
Current Assets	6.44	15.23	49.18	22.82	28.51	28.62
Total Assets	16.10	21.88	56.28	29.90	29.89	30.25
Total Debt*	3.46	6.17	7.32	7.82	0.08	--
Net Current Assets	-0.79	8.60	41.22	13.14	23.53	22.77

Cashflow ($ Mln)	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Cash From Operating Activities	--	-32.14	-41.79	-33.15	-29.00	-23.22
Cash Flow from Investing Activities	--	-0.24	-0.80	-0.80	23.20	-23.29
Cash from Financing Activities	--	-1.16	68.21	28.40	27.20	38.88
Net Cash Inflow / Outflow	--	--	--	-4.75	21.40	-7.64

Financials Ratios	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
ROCE (%)	--	-118.50	-134.65	-183.48	-128.05	-232.81
ROE (%)	--	-154.68	-173.90	-221.51	-128.28	-232.81
ROA (%)	-106.20	-87.47	-104.82	-141.33	-100.69	-172.11
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	-14,661.76	-19,178.93	6,927.64
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	25.19	23.50	-11.45	-42.71	15.76	-68.34
Net Profit Growth (%)	26.19	24.33	-6.90	-39.56	22.64	-82.46
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.78	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.04	0.17	0.82	0.30	0.84	0.83
Close Price ($)	2.20	15.84	47.96	92.40	49.06	272.80
High Price ($)	31.90	53.24	179.52	107.58	431.20	649.00
Low Price ($)	1.50	14.66	45.76	22.86	44.44	193.60
Market Cap ($ Cr)	1.65	--	--	--	--	--

Solvency Ratios	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Debt to Equity	-0.35	1.01	0.19	0.56	0.00	--
Short term debt to equity ratio	-0.24	0.33	0.05	0.11	0.00	--
Current Ratio	0.89	2.30	6.18	2.36	5.73	4.89
Quick Ratio	0.89	--	--	--	--	4.89
Interest Coverage	-626.66	-1,768.80	-3,051.02	-8,488.28	-7,993.87	-5.67

Operating Efficiency Ratios	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.